Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs ZIM Integrated Shipping Services Ltd — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while ZIM Integrated Shipping Services Ltd trades at $29.84 (market cap $3.67B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 2.4× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and ZIM Integrated Shipping Services Ltd for 23 Days on average.
| KYMR | ZIM | |
|---|---|---|
Market Cap | $8.87B | $3.67B |
Volume | 779,107 | 1,172,596 |
Sector | Health | Industrials |
52-Week High | $127.31 | $30.90 |
52-Week Low | $55.80 | $13.32 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $8.26B | $7.34B |
Dividend Yield | — | 20.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ZIM trades at $30.43, down 1.52% on the day, with a bullish technical signal from moving averages. The stock is near its 52-week high of $30.96, reflecting strong momentum. Fundamentally, Q2 2026 earnings of $0.53 per share significantly beat expectations, driven by a 9% revenue increase to $1.8 billion, though full-year 2026 guidance indicates margin pressure. The pending $35 per share acquisition offer from Hapag-Lloyd, subject to Israeli government approval, creates a key near-term catalyst.
The investment case balances potential upside from the acquisition against operational risks. If approved, the deal offers immediate premium; if rejected, ZIM's standalone value hinges on sustaining high transpacific freight rates. Analyst sentiment is cautious with no buy ratings, highlighting execution and geopolitical risks. The stock presents a speculative opportunity with binary outcomes centered on the merger decision.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About ZIM Integrated Shipping Services Ltd
ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →
